Merck KGaA (OTCMKTS:MKKGY) Short Interest Update

Merck KGaA (OTCMKTS:MKKGY) was the recipient of a large increase in short interest in December. As of December 15th, there was short interest totaling 241,637 shares, an increase of 234.9% from the November 30th total of 72,150 shares. Based on an average trading volume of 280,839 shares, the short-interest ratio is presently 0.9 days. Approximately 0.0% of the shares of the stock are short sold. Approximately 0.0% of the shares of the stock are short sold. Based on an average trading volume of 280,839 shares, the short-interest ratio is presently 0.9 days.

Merck KGaA Stock Up 0.2%

Shares of OTCMKTS MKKGY opened at $28.45 on Friday. The company has a current ratio of 1.49, a quick ratio of 0.97 and a debt-to-equity ratio of 0.36. The business has a 50-day moving average of $26.95 and a 200-day moving average of $26.33. The firm has a market capitalization of $18.38 billion, a price-to-earnings ratio of 11.33, a PEG ratio of 5.71 and a beta of 0.97. Merck KGaA has a 12 month low of $24.32 and a 12 month high of $31.80.

Merck KGaA (OTCMKTS:MKKGY) last announced its earnings results on Thursday, November 13th. The company reported $0.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.27. Merck KGaA had a net margin of 13.92% and a return on equity of 10.07%. The business had revenue of $6.17 billion during the quarter, compared to analyst estimates of $6.08 billion. Sell-side analysts expect that Merck KGaA will post 1.87 earnings per share for the current fiscal year.

About Merck KGaA

Merck KGaA, Darmstadt, Germany, commonly referred to as Merck Group, is a multinational science and technology company with origins dating back to 1668. The company develops and manufactures products and technologies across healthcare, life science and electronics applications. It is distinct from the U.S. pharmaceutical company Merck & Co; Merck KGaA is a European group headquartered in Darmstadt and is publicly listed in Germany with an OTC American depositary receipt available under the symbol MKKGY.

Merck’s Healthcare business develops prescription medicines and related services focused on areas such as oncology, immunology, neurology (including therapies for multiple sclerosis) and fertility.